David Ledbetter Ph.D., FACMG

David H. Ledbetter, Ph.D., FACMG, is a Professor and the Senior Associate Director for Precision Medicine with the Florida Institute for Pediatric Rare Diseases (IPRD). An internationally recognized expert in human genetics, he is clinically trained and board certified by the American Board of Medical Genetics and Genomics in Clinical Cytogenetics. He has a primary research focus on finding the genetic causes of pediatric neurodevelopmental disorders including autism spectrum disorder, intellectual disability, epilepsy and cerebral palsy. He previously led one of the largest biobanks and clinical genomics programs in the world, the MyCode Community Health Initiative at Geisinger Health in Pennsylvania. He moved to FSU in early 2025 to build a clinical genomics program in North Florida and to Chair the Steering Committee for Sunshine Genetics, a state-funded pediatric genetics network developing and launching a genomic newborn screening pilot program for 100,000 Florida newborns over the next five years.